Therefore, our study provides a ground‐breaking exploration into the molecular mechanism by which downregulation of SLC3A2 expression mediates immune escape and accelerates disulphide death in tumour cells, further advancing the progression of TSCC. Here, SLC3A2 is linked to neoplasm.